Risk of neurologic or immune-mediated adverse events after COVID-19 diagnosis in the United States. - Fisher, Shelby S.; Lindaas, Arnstein; Muthuri, Stella G.; Lloyd, Patricia C.; Gruber, Joann F.; Richey, Morgan M.; Lyu, Hai; Cheng, Angela S.; Kowarski, Lisa S.; McKillop, Mollie M.; Bui, Christine; Clarke, Tainya C.; et al. (PLoS ONE, 2025)